Concepedia

K Parker

KP

8

Publications

745

Citations

8

H-Index

1987

Active since

Affiliations

The University of Texas Health Science Center at San Antonio(Current)

Monash Health

Royal Children's Hospital

The University of Melbourne

Boston Medical Center

K Parker is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

1987–2024

8

Publications

8

Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein

Diane P. Williams, K Parker, Patricia Bacha et al. · Protein Engineering Design and Selection · 1987 · 235 citations

Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor

CF LeMaistre, C Meneghetti, Michael G. Rosenblum et al. · Blood · 1992 · 157 citations · Full text

Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor

CF LeMaistre, C Meneghetti, Michael G. Rosenblum et al. · Blood · 1992 · 127 citations

Phase I trial of a 90-minute infusion of the fusion toxin DAB486IL-2 in hematological cancers.

C. Frederick LeMaistre, Fiona E. Craig, C Meneghetti et al. · PubMed · 1993 · 90 citations

, , +21

Clinical activity of a cytotoxic fusion protein in the treatment of cutaneous T-cell lymphoma.

Paul J. Hesketh, Priscilla B. Caguioa, Howard K. Koh et al. · Journal of Clinical Oncology · 1993 · 59 citations

Rows per page

1–5 of 8